Literature DB >> 21289238

Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension.

Yoshitaka Hirooka1, Takuya Kishi, Koji Sakai, Akira Takeshita, Kenji Sunagawa.   

Abstract

Nitric oxide (NO) and reactive oxygen species (ROS) play important roles in blood pressure regulation via the modulation of the autonomic nervous system, particularly in the central nervous system (CNS). In general, accumulating evidence suggests that NO inhibits, but ROS activates, the sympathetic nervous system. NO and ROS, however, interact with each other. Our consecutive studies and those of others strongly indicate that an imbalance between NO bioavailability and ROS generation in the CNS, including the brain stem, activates the sympathetic nervous system, and this mechanism is involved in the pathogenesis of neurogenic aspects of hypertension. In this review, we focus on the role of NO and ROS in the regulation of the sympathetic nervous system within the brain stem and subsequent cardiovascular control. Multiple mechanisms are proposed, including modulation of neurotransmitter release, inhibition of receptors, and alterations of intracellular signaling pathways. Together, the evidence indicates that an imbalance of NO and ROS in the CNS plays a pivotal role in the pathogenesis of hypertension.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289238     DOI: 10.1152/ajpregu.00426.2010

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  45 in total

1.  Effect of acute dietary nitrate supplementation on sympathetic vasoconstriction at rest and during exercise.

Authors:  Christopher J de Vries; Darren S DeLorey
Journal:  J Appl Physiol (1985)       Date:  2019-05-16

2.  Angiotensin II type 2 receptor-coupled nitric oxide production modulates free radical availability and voltage-gated Ca2+ currents in NTS neurons.

Authors:  Gang Wang; Christal G Coleman; Michael J Glass; Ping Zhou; Qi Yu; Laibaik Park; Josef Anrather; Virginia M Pickel; Costantino Iadecola
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-02-29       Impact factor: 3.619

Review 3.  The roles of sensitization and neuroplasticity in the long-term regulation of blood pressure and hypertension.

Authors:  Alan Kim Johnson; Zhongming Zhang; Sarah C Clayton; Terry G Beltz; Seth W Hurley; Robert L Thunhorst; Baojian Xue
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-19       Impact factor: 3.619

Review 4.  Neuroinflammatory and autonomic mechanisms in diabetes and hypertension.

Authors:  Cheng Han; Matthew W Rice; Dongsheng Cai
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-10       Impact factor: 4.310

Review 5.  Post-translational regulation of neuronal nitric oxide synthase: implications for sympathoexcitatory states.

Authors:  Neeru M Sharma; Kaushik P Patel
Journal:  Expert Opin Ther Targets       Date:  2016-12-02       Impact factor: 6.902

Review 6.  Central modulation of cyclosporine-induced hypertension.

Authors:  Hanan M El-Gowelli; Mahmoud M El-Mas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-29       Impact factor: 3.000

7.  Pretreatment of liver grafts in vivo by γ-aminobutyric acid receptor regulation reduces cold ischemia/warm reperfusion injury in rat.

Authors:  Tomohide Hori; Lindsay B Gardner; Toshiyuki Hata; Feng Chen; Ann-Marie T Baine; Shinji Uemoto; Justin H Nguyen
Journal:  Ann Transplant       Date:  2013-06-17       Impact factor: 1.530

Review 8.  Cardiovascular Autonomic Dysfunction in Chronic Kidney Disease: a Comprehensive Review.

Authors:  Ibrahim M Salman
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

9.  Liver graft pretreated in vivo or ex vivo by γ-aminobutyric acid receptor regulation.

Authors:  Tomohide Hori; Lindsay B Gardner; Florence Chen; Ann-Marie T Baine; Toshiyuki Hata; Shinji Uemoto; Justin H Nguyen
Journal:  J Surg Res       Date:  2012-09-15       Impact factor: 2.192

Review 10.  Apelin/APJ system: a promising therapy target for hypertension.

Authors:  Di Wu; Lu He; Linxi Chen
Journal:  Mol Biol Rep       Date:  2014-07-03       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.